ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 122 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,857,000 | +118.8% | 473,973 | +30.7% | 0.00% | – |
| Q3 2019 | $1,306,000 | -41.4% | 362,720 | -56.4% | 0.00% | -100.0% |
| Q2 2019 | $2,228,000 | +961.0% | 831,397 | +1077.0% | 0.00% | – |
| Q1 2019 | $210,000 | -55.2% | 70,636 | -76.1% | 0.00% | – |
| Q4 2018 | $469,000 | -47.3% | 295,408 | +22.1% | 0.00% | – |
| Q3 2018 | $890,000 | -2.6% | 241,958 | -25.1% | 0.00% | – |
| Q2 2018 | $914,000 | -24.1% | 323,089 | -0.4% | 0.00% | – |
| Q1 2018 | $1,205,000 | -91.3% | 324,522 | -93.3% | 0.00% | -100.0% |
| Q4 2017 | $13,855,000 | +497.5% | 4,810,589 | +831.4% | 0.00% | +300.0% |
| Q3 2017 | $2,319,000 | +68.4% | 516,501 | +72.2% | 0.00% | – |
| Q2 2017 | $1,377,000 | -91.5% | 299,976 | -92.2% | 0.00% | -100.0% |
| Q1 2017 | $16,124,000 | -18.4% | 3,829,806 | -19.9% | 0.00% | -33.3% |
| Q4 2016 | $19,748,000 | +571.7% | 4,781,664 | +1217.1% | 0.00% | +200.0% |
| Q3 2016 | $2,940,000 | +222.7% | 363,057 | +211.0% | 0.00% | – |
| Q2 2016 | $911,000 | +203.7% | 116,749 | +201.1% | 0.00% | – |
| Q1 2016 | $300,000 | -88.1% | 38,769 | -83.4% | 0.00% | -100.0% |
| Q4 2015 | $2,517,000 | +1210.9% | 233,221 | +738.4% | 0.00% | – |
| Q3 2015 | $192,000 | -22.3% | 27,816 | -0.3% | 0.00% | – |
| Q2 2015 | $247,000 | -97.3% | 27,911 | -97.0% | 0.00% | -100.0% |
| Q1 2015 | $9,111,000 | +2111.4% | 924,059 | +2643.8% | 0.00% | – |
| Q4 2014 | $412,000 | -79.5% | 33,678 | -83.3% | 0.00% | -100.0% |
| Q3 2014 | $2,013,000 | -72.7% | 201,797 | -79.3% | 0.00% | -66.7% |
| Q2 2014 | $7,385,000 | +268.1% | 975,645 | +60.0% | 0.00% | +200.0% |
| Q1 2014 | $2,006,000 | -21.5% | 609,801 | -20.8% | 0.00% | 0.0% |
| Q4 2013 | $2,555,000 | +416.2% | 769,510 | +368.7% | 0.00% | – |
| Q3 2013 | $495,000 | -76.0% | 164,187 | -34.8% | 0.00% | -100.0% |
| Q2 2013 | $2,059,000 | – | 251,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |